Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 5/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7347720 | 1.00 | ALDH1A1 (0.38) | ALDH1A1USP2SMN1; SMN2LMNAKDM4E | |
| SCHEMBL901643 | 0.94 | ALDH1A1 (0.33) | ALDH1A1USP2SMN1; SMN2LMNAKDM4E | |
| SCHEMBL343088 | 0.94 | ALDH1A1 (0.33) | ALDH1A1USP2SMN1; SMN2LMNAKDM4E | |
| SCHEMBL6687035 | 0.79 | — | — | |
| SCHEMBL377817 | 0.76 | — | — | |
| SCHEMBL30918323 | 0.74 | EPHX2 (0.42) | ALDH1A1LMNAHPGDMEN1KMT2A | |
| Acetic Acid SCHEMBL2995772 | 0.74 | DPP4 (0.33) | ALDH1A1USP2SMN1; SMN2LMNAKDM4E | |
| SCHEMBL8923859 | 0.72 | — | — | |
| SCHEMBL28419139 | 0.72 | — | — | |
| SCHEMBL8074920 | 0.72 | SLC6A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3008037-B1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2018-09-26 | — | — | EP | claimed |
| EP-2673287-B1 | AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2017-08-30 | — | — | EP | claimed |
| EP-3008037-A1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2016-04-20 | — | — | EP | claimed |
| EP-2877485-A1 | HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2015-06-03 | — | — | EP | claimed |
| WO-2014198372-A1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2014-12-18 | — | — | WO | claimed |
| WO-2014015934-A1 | HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2014-01-30 | — | — | WO | claimed |
| EP-2673287-A1 | AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2013-12-18 | — | — | EP | claimed |
| WO-2012107153-A1 | AMINO STATIN DERIVATIVESFOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2012-08-16 | — | — | WO | claimed |
| EP-3008037-B1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2018-09-26 | — | — | EP | disclosed |
| EP-2877485-B1 | HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2018-03-14 | — | — | EP | disclosed |
| EP-2673287-B1 | AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2017-08-30 | — | — | EP | disclosed |
| EP-3008037-A1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2016-04-20 | — | — | EP | disclosed |
| EP-2945929-A1 | ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS | Merck Patent GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2877485-A1 | HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2015-06-03 | — | — | EP | disclosed |
| EP-0717736-A4 | POLAR-SUBSTITUTED HYDROCARBONS | NARHEX LTD (HK) | 1996-08-28 | — | — | EP | disclosed |
| EP-0717736-A1 | POLAR-SUBSTITUTED HYDROCARBONS | NARHEX LIMITED (HK) | 1996-06-26 | — | — | EP | disclosed |
| EP-0683772-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-11-29 | — | — | EP | disclosed |
| EP-0683772-A4 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS. | ABBOTT LAB (US) | 1995-09-27 | — | — | EP | disclosed |
| WO-1995007269-A1 | POLAR-SUBSTITUTED HYDROCARBONS | NARHEX LIMITED (HK) | 1995-03-16 | — | — | WO | disclosed |
| WO-1994019332-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1994-09-01 | — | — | WO | disclosed |